Interlaboratory Comparison of Porcine Circovirus-2 Indirect Immunofluorescent Antibody Test and Enzyme-Linked Immunosorbent Assay Results on Experimentally Infected Pigs
Open Access
- 1 March 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Veterinary Diagnostic Investigation
- Vol. 23 (2) , 206-212
Abstract
A blinded interlaboratory assessment of the diagnostic agreement and accuracy of serologic tests for routine detection of antibodies against Porcine circovirus-2 (PCV-2), including indirect fluorescent antibody tests (IFATs) and enzyme-linked immunosorbent assays (ELISAs) was conducted in 7 North American laboratories. Serum samples were collected weekly, on trial days 0, 7, 14, 21, 28, 35, 42, and 49, from the following groups of animals: 1) negative controls (n = 7), 2) PCV-2a (n = 8), 3) PCV-2b (n = 8), 4) PCV-1 (n = 8), 5) PCV-2 vaccine A (n = 8; Ingelvac® CircoFLEX™), 6) PCV-2 vaccine B (n = 8; Circumvent® PCV2), and 7) PCV-2 vaccine C (n = 8; Suvaxyn® PCV2 One Dose). Results from each laboratory were analyzed by kappa and receiver operating characteristic (ROC) analysis. Kappa analysis indicated that, by trial day 49, IFATs had almost perfect agreement, in-house ELISAs had fair to almost perfect agreement, and commercially available anti–PCV-2 immunoglobulin G ELISAs (I or S) had moderate to substantial agreement. From trial days 14–49, the area under the ROC curve for the 2 laboratories that offered IFATs, the 4 laboratories that offered in-house ELISAs, and the 3 laboratories that used commercially available ELISAs ranged from 0.94 to 1.00, 0.72 to 1.00, and 0.95 to 1.00, respectively. However, test sensitivities varied based on laboratory-specific cutoffs that were used to dichotomize test results.Keywords
This publication has 18 references indexed in Scilit:
- A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2Journal of the American Veterinary Medical Association, 2008
- Influence of Maternal Antibodies on Efficacy of Porcine Circovirus Type 2 (PCV2) Vaccination To Protect Pigs from Experimental Infection with PCV2Clinical and Vaccine Immunology, 2008
- The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complexVaccine, 2008
- Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2Research in Veterinary Science, 2008
- Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic originsVaccine, 2008
- Expression of the porcine circovirus type 2 capsid protein subunits and application to an indirect ELISAJournal of Biotechnology, 2008
- Immunogenicity and Pathogenicity of Chimeric Infectious DNA Clones of Pathogenic Porcine Circovirus Type 2 (PCV2) and Nonpathogenic PCV1 in Weanling PigsJournal of Virology, 2003
- Characterization of Immune Response of Young Pigs to Porcine Circovirus Type 2 InfectionViral Immunology, 2000
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983
- A very small porcine virus with circular single-stranded DNANature, 1982